Th17/CD4^+ CD25^+ Treg细胞失衡与儿童急性再生障碍性贫血免疫发病机制的关系
被引量:2
摘要
我国是儿童急性再生障碍性贫血(aplastic anemia,AA)的高发国家。然而急性AA的发病机制尚不明确,治疗措施针对性不强,导致其治疗效果不佳,病死率极高。Th17细胞及其分泌的细胞因子介导炎症反应,能诱导严重自身免疫性疾病;
出处
《中国小儿血液与肿瘤杂志》
CAS
2011年第1期38-41,共4页
Journal of China Pediatric Blood and Cancer
参考文献21
-
1Solomou EE, Rezvani K, Mielke S, et al. Deficient CD4 + CD25 + FOXP3 + T regulatory cells in acquired aplastie anemia. Blood, 2007,110 : 1603-1606.
-
2Yan Gu, Xiaojing Hu, Chuanfang Liu, et al. Interleukin (IL)-17 promotes macrophages to produce IL-8, IL-6 and tumour necrosis factor-a in aplastic anaemia. Br J Haematol, 2008, 142 : 109-114.
-
3Wahl SM. Transforming growth factor-beta: innately bipolar. Curt Opin Immunol, 2007, 19:55-62.
-
4Kom T, Bettelli E, Gao W, et al. IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells. Nature, 2007,448: 484-488.
-
5Huber M, Brustle A, Reinhard K, et al. IRF4 is essential for IL-21- mediated induction, amplification, and stabilization of the Thl7 phenotype. Proc Natl Acad Sci USA, 2008, 105:20546-20851.
-
6Laurence A, Tato CM, Davidson TS, et al. lnterleukin-2 Signaling via STAT5 Constrains T Helper 17 Cell Generation. Immunity, 2007, 26: 371-381.
-
7Fitzgerald DC, Ciric B, Touil T, et al. Suppressive Effect of IL-27 on Encephalitogenic Th17 Ceils and the Effector Phase of Experimental Autoirranune Encephalomyelitis. J Immunol, 2007, 179: 3268-3275.
-
8Kleinschek MA, Owyang AM, Joyce-Shaikh B, et al. IL-25 regulates 33317 function in autoimmune inflammation. JEM, 2007, 204: 161-170.
-
9Ivanov II, McKenzie BS, Zhou L, et al. The orphan nuclear receptor RORgt directs the differentiation program of proinflammatory IL-17 + T helper cells. Cell, 2006, 126: 1121-1133.
-
10Annunziato F, Cosmi L, Liotta F,et al. The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation. Int Immunol, 2008, 20 : 1361-1368.
同被引文献21
-
1黄绍良,黄永兰.儿童特发性再生障碍性贫血的诊断与治疗[J].中国当代儿科杂志,2009,11(2):81-87. 被引量:4
-
2Young NS, Bacigalupo A, Marsh JC. Aplastic anemia:Pathophysiology and treatment[ J]. Biol Blood Marrow Transplant,2010,16 (1 suppl) : 119 - 125.
-
3Chang MH, Kim KH, Kim HS,et al. Predictors of response to immuno- suppressive therapy with antithymocyte globulin and cyclosporine and prognostic factors for survival in patients with severe aplastic anemia [J]. Eur J Haematol,2010,84(2) :154 - 159.
-
4Scheinberg P, Colin OW, Nunez O,et al. Treatment of severe aplastic a- nemia with a combination of horse antithymocyte globulin and eyelospo- fine, with or without sirolimus: A prospective randomized study [ J ]. Haematologica,2009, 94 ( 3 ) : 348 - 354.
-
5Sakaguchi S,Miyara M,Costantino CM,et al.FOXP3+ regulatory T cells in the human immune system[J].Nat Rev Immunol,2010,10:490-500.
-
6Afzali B,Lombardi G,Lechler RI,et al.The role ofT helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease[J].Clin Exp Immunol,2007,48:32-46.
-
7de Latour RP,Visconte V,Takaku T,et al.Th17 immune responses contribute to the pathophysiology of aplastic anemia[J].Blood,2010,116:4175-4184.
-
8Shi J,Ge M,Lu S,et al.Intrinsic impairment of CD4(+)CD25 (+) regulatory T cells in acquired aplastic anemia[J].Blood,2012,120:1624-1632.
-
9Young NS.Current concepts in the pathophysiology and treatment of aplastic anemia[J].Hematology Am Soc Hematol Educ Program,2013:76-81.
-
10Passweg JR,Aljurf M.Treatment and hematopoietic SCT in aplastic anemia[J].Bone Marrow Transplant,2013,48:161.
引证文献2
-
1苏淑芳,吕艳琦,李白,刘玉峰.急性重型再生障碍性贫血72例[J].实用儿科临床杂志,2012,27(15):1185-1186. 被引量:8
-
2刘亢亢,王会平,谢志伟,储金华,汪燕,戴煜,杨林海,谈静,王宁玲.Th17/Treg细胞失衡在儿童再生障碍性贫血免疫发病及治疗中的意义[J].中华儿科杂志,2014,52(12):927-931. 被引量:4
二级引证文献12
-
1谢晓恬,赵惠君,覃大卫.抗胸腺细胞球蛋白治疗儿童再生障碍性贫血药代动力学研究[J].中华实用儿科临床杂志,2013,28(15):1134-1137. 被引量:6
-
2乔晓红,谢晓恬,石苇,邵越霞,卢双龙,顾昶娟.儿童肝炎相关再生障碍性贫血循证医学分析[J].中华实用儿科临床杂志,2013,28(15):1155-1158. 被引量:12
-
3王秋红.不同治疗方案在儿童急性重型再生障碍性贫血中的应用比较[J].中西医结合心血管病电子杂志,2014(4):110-111. 被引量:1
-
4苏雁,吴润晖,马洁,周翾,张蕊.兔抗胸腺细胞球蛋白联合环孢素免疫抑制治疗儿童重型再生障碍性贫血的疗效[J].中华实用儿科临床杂志,2015,30(3):189-193. 被引量:27
-
5文鸿光.补肾归脾汤加减联合丙酸睾丸酮治疗小儿再生障碍性贫血疗效分析[J].中国伤残医学,2015,23(6):144-145.
-
6李源.使用环孢素A联合十一酸睾酮治疗再生障碍性贫血的效果分析[J].当代医药论丛,2016,14(6):112-113. 被引量:1
-
7刘翠红.健康教育路径在重型再生障碍性贫血患者护理中的应用与效果[J].中国医学工程,2016,24(6):16-20. 被引量:5
-
8安娜,张莹石,李清.临床药师参与老年急性再生障碍性贫血患者的药学监护[J].中国医院用药评价与分析,2016,16(8):1140-1142. 被引量:1
-
9牟丹丹,倪圆圆,李婷婷,宋丽君.Th17、Treg细胞及其在肺炎支原体肺炎中的研究进展[J].中国妇幼保健,2016,31(21):4601-4603. 被引量:10
-
10宋丽,李府,杨晓梅,刘毅,吕欣,张开慧,黄志伟,王亚屏,姬牧远,张乐玲.肿瘤坏死因子α诱导蛋白8-2在再生障碍性贫血患儿骨髓中的表达及意义[J].中华实用儿科临床杂志,2016,31(24):1898-1901. 被引量:6
-
1张琦,董亮,李丽珍,于钦凤,陈明.以T-bet/GATA-3的比率作为评价哮喘患者Th1/Th2失衡指标的探讨[J].细胞与分子免疫学杂志,2005,21(1):118-119. 被引量:12
-
2吕婷婷,刘立新.自身免疫性肝病发病机制的研究进展[J].中华消化病与影像杂志(电子版),2017,7(2):75-78. 被引量:9
-
3李彦格,张红梅,李慧霞,毛彦娜,刘炜,刘俊闪.儿童急性再生障碍性贫血淋巴细胞亚群的变化及意义[J].中国实用医刊,2012,39(4):38-39. 被引量:1
-
4谢晓恬,王耀平,姚慧玉,应大明.静脉输注大剂量丙种球蛋白治疗儿童急性再生障碍性贫血[J].中华血液学杂志,1994,15(4):174-175. 被引量:13
-
5王少扬,张树林.Th1/Th2细胞失衡与慢性乙型肝炎[J].国外医学(流行病学.传染病学分册),1998,25(5):202-204. 被引量:7
-
6黄可,沈瑛,樊满齐,杨伟康,刘翱.Treg/Th17细胞在不同时期慢性阻塞性肺疾病患者中的改变及意义探讨[J].国际呼吸杂志,2015,35(7):504-507. 被引量:7
-
7赖忠庆.1型糖尿病患者外周血调节性T细胞/Th17细胞失衡的临床意义[J].现代实用医学,2014,26(11):1386-1388.
-
8时国朝,万欢英.支气管哮喘的免疫发病机制——从Th1/Th2细胞失衡到Th2/Treg细胞失衡[J].内科理论与实践,2011,6(2):92-95. 被引量:27
-
9王华英,翁跃颂,应华娟,俞万钧.慢性阻塞性肺疾病患者 Th17/Treg 细胞失衡与肺功能相关性研究[J].中华微生物学和免疫学杂志,2014,34(7):527-533. 被引量:37
-
10刘光亮,周小兰,陶鹏.Th17/Treg细胞亚群数量变化在HBV相关ACLF临床转归中的作用[J].免疫学杂志,2014,30(7):623-627. 被引量:10